article thumbnail

Xylazine and Opioid Overdoses Spur Government Action

National Association of Boards of Pharmacy

Furthermore, xylazine is also associated with physical dependence, withdrawal symptoms, and a general substance use disorder (SUD). While federal law does not classify the drug as a controlled substance (CS), some states have enacted laws or temporary orders to regulate its possession, distribution, and use.

article thumbnail

FDA Seeks $7.2 Billion to Protect and Advance Public Health

LifeProNow

March 09, 2023: “The U.S. The request includes an increase of $372 million in budget authority — or 10% above the FY 2023 Enacted Level — and a $150 million increase in user fees. 1, 2023, through Sept. Food and Drug Administration announced it is requesting $7.2 The FY 2024 request, which covers the period from Oct.

Labelling 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Internet Pharmacies are an Often-Overlooked Part of the Medicines Supply Chain

Quality Matters

The challenges associated with online pharmacies are not just limited to the distribution of counterfeit medicines – they also include the potential to exacerbate addiction and substance abuse through the availability of controlled substances. kristine.gates… Tue, 05/23/2023 - 10:25 Supply Chain

article thumbnail

Governors’ Push President on Cannabis Rescheduling But Overlook What Schedule III Would Require

FDA Law Blog: Biosimilars

The governors (of Colorado, Illinois, Louisiana, Maryland, New Jersey and New York) thanked the President for his leadership in directing the Department of Health and Human Services (“HHS”) to reconsider the current scheduling of cannabis and HHS’ August 2023 rescheduling recommendation to the Drug Enforcement Administration (“DEA”).